Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Renner, Andreas [VerfasserIn]   i
 Stoshikj, Slagjana [VerfasserIn]   i
 Pohl, Wolfgang [VerfasserIn]   i
 Bal, Christina [VerfasserIn]   i
 Reisinger, Matthias [VerfasserIn]   i
 Löffler-Ragg, Judith [VerfasserIn]   i
 Zacharasiewicz, Angela [VerfasserIn]   i
 Buhl, Roland [VerfasserIn]   i
 Hamelmann, Eckard [VerfasserIn]   i
 Taube, Christian [VerfasserIn]   i
 Korn, Stephanie [VerfasserIn]   i
 Idzko, Marco [VerfasserIn]   i
Titel:Characterization of Austrian severe asthma patients
Verf.angabe:Andreas Renner, Slagjana Stoshikj, Wolfgang Pohl, Christina Bal, Matthias Reisinger, Judith Löffler-Ragg, Angela Zacharasiewicz, Roland Buhl, Eckard Hamelmann, Christian Taube, Stephanie Korn, Marco Idzko
E-Jahr:2023
Jahr:10 October 2023
Umfang:8 S.
Illustrationen:Diagramme
Fussnoten:Gesehen am 18.03.2024
Titel Quelle:Enthalten in: Respiratory medicine
Ort Quelle:Burlington, Mass. : Harcourt, 1999
Jahr Quelle:2023
Band/Heft Quelle:219(2023) vom: Nov./Dez., Artikel-ID 107427, Seite 1-8
ISSN Quelle:1532-3064
Abstract:Introduction - The Severe Asthma Registry, founded by German Asthma Net (GAN) in 2011, is a prospective registry recording clinical parameters from participating centers in Germany, Austria and Switzerland. This article presents the baseline characteristics of severe asthma patients from Austrian centers. - Methods - We analyzed the baseline visit data of all patients recruited to the GAN Severe Asthma Registry from participating Austrian centers. - Results - Baseline visit data were available for 214 Austrian severe asthma patients from 6 Austrian centers from 2013 to 2022. Mean age was 53.7 years. Mean BMI was 26.4 kg/m2. More than a third (37.4%) of all patients had daily daytime asthma symptoms at baseline and had to use their reliever medication at least once per day. Forty-one percent of patients were classified as uncontrolled according to GINA and 24.8% as partially controlled at baseline visit. The median annual exacerbation frequency was 3 in the previous 12 months. At the time of baseline visit, 23.4% of all patients had regular treatment with oral corticosteroids. Furthermore, 23.9% had received any severe asthma monoclonal antibody prior to the baseline visit. There were no notable differences in baseline characteristics between patients categorized by smoking history or measurable type 2 inflammation. - Conclusions - This study provides the first multi-center characterization of Austrian severe asthma patients. Patients in this cohort had better asthma control and less frequent exacerbations compared to most international registries.
DOI:doi:10.1016/j.rmed.2023.107427
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1016/j.rmed.2023.107427
 kostenfrei: Volltext: https://www.sciencedirect.com/science/article/pii/S0954611123003153
 DOI: https://doi.org/10.1016/j.rmed.2023.107427
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Asthma
 Asthma control
 Biologics
 Registry data
 Severe asthma
 Type-2-inflammation
K10plus-PPN:1883657008
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69192742   QR-Code
zum Seitenanfang